Literature DB >> 19264436

Imaging oncogene expression.

Archana Mukherjee1, Eric Wickstrom, Mathew L Thakur.   

Abstract

This review briefly outlines the importance of molecular imaging, particularly imaging of endogenous gene expression for noninvasive genetic analysis of radiographic masses. The concept of antisense imaging agents and the advantages and challenges in the development of hybridization probes for in vivo imaging are described. An overview of the investigations on oncogene expression imaging is given. Finally, the need for further improvement in antisense-based imaging agents and directions to improve oncogene mRNA targeting is stated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264436      PMCID: PMC2680925          DOI: 10.1016/j.ejrad.2009.01.043

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  64 in total

Review 1.  Molecular imaging.

Authors:  R Weissleder; U Mahmood
Journal:  Radiology       Date:  2001-05       Impact factor: 11.105

2.  Continuous solid-phase synthesis and disulfide cyclization of peptide-PNA-peptide chimeras.

Authors:  Xiaobing Tian; Eric Wickstrom
Journal:  Org Lett       Date:  2002-11-14       Impact factor: 6.005

3.  Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice.

Authors:  N Sato; H Kobayashi; T Saga; Y Nakamoto; T Ishimori; K Togashi; Y Fujibayashi; J Konishi; M W Brechbiel
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

4.  Antisense imaging of epidermal growth factor-induced p21(WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts.

Authors:  Judy Wang; Paul Chen; Marko Mrkobrada; Meiduo Hu; Katherine A Vallis; Raymond M Reilly
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-15       Impact factor: 9.236

5.  99mTc-peptide-peptide nucleic acid probes for imaging oncogene mRNAs in tumours.

Authors:  P S Rao; X Tian; W Qin; M R Aruva; E R Sauter; M L Thakur; E Wickstrom
Journal:  Nucl Med Commun       Date:  2003-08       Impact factor: 1.690

6.  Selective cytotoxicity to human leukemic myeloblasts produced by oligodeoxyribonucleotide phosphorothioates complementary to p53 nucleotide sequences.

Authors:  E Bayever; K M Haines; P L Iversen; R W Ruddon; S J Pirruccello; C P Mountjoy; M A Arneson; L J Smith
Journal:  Leuk Lymphoma       Date:  1994-01

7.  Radiometal-labeled peptide-PNA conjugates for targeting bcl-2 expression: preparation, characterization, and in vitro mRNA binding.

Authors:  Michael R Lewis; Fang Jia; Fabio Gallazzi; Yi Wang; Jiuli Zhang; Nalini Shenoy; Susan Z Lever; Mark Hannink
Journal:  Bioconjug Chem       Date:  2002 Nov-Dec       Impact factor: 4.774

Review 8.  In vivo imaging with oligonucleotides for diagnosis and drug development.

Authors:  B Tavitian
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

9.  Delivery agents for oligonucleotides.

Authors:  Olivier Seksek; Jacques Bolard
Journal:  Methods Mol Biol       Date:  2004

10.  Imaging gene expression using oligonucleotides and peptide nucleic acids.

Authors:  Zain Paroo; David R Corey
Journal:  J Cell Biochem       Date:  2003-10-15       Impact factor: 4.429

View more
  5 in total

1.  Radiolabeled oligonucleotides for antisense imaging.

Authors:  Arun K Iyer; Jiang He
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

2.  Native mRNA antisense-accessible sites library for the selection of antisense oligonucleotides, PNAs, and siRNAs.

Authors:  Huafeng Fang; Yuefei Shen; John-Stephen Taylor
Journal:  RNA       Date:  2010-05-24       Impact factor: 4.942

3.  Effects of hypoxanthine substitution in peptide nucleic acids targeting KRAS2 oncogenic mRNA molecules: theory and experiment.

Authors:  Jeffrey M Sanders; Matthew E Wampole; Chang-Po Chen; Dalip Sethi; Amrita Singh; François-Yves Dupradeau; Fan Wang; Brian D Gray; Mathew L Thakur; Eric Wickstrom
Journal:  J Phys Chem B       Date:  2013-09-18       Impact factor: 2.991

4.  Application and Evaluation of [99mTc]-Labeled Peptide Nucleic Acid Targeting MicroRNA-155 in Breast Cancer Imaging.

Authors:  Yaqun Jiang; Yongkang Gai; Yu Long; Qingyao Liu; Chunbao Liu; Yongxue Zhang; Xiaoli Lan
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488

Review 5.  Positron emission tomography molecular imaging-based cancer phenotyping.

Authors:  Chentao Jin; Xiaoyun Luo; Xiaoyi Li; Rui Zhou; Yan Zhong; Zhoujiao Xu; Chunyi Cui; Xiaoqing Xing; Hong Zhang; Mei Tian
Journal:  Cancer       Date:  2022-04-13       Impact factor: 6.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.